Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28642 | 165 | 41.7 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
495 | 14696 | RADIATION RESEARCH//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//AMIFOSTINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BIOMARKERS BRANCH | Address | 1 | 50% | 1% | 1 |
2 | CLONOGEN | Author keyword | 1 | 50% | 1% | 1 |
3 | COLORADO PARTY | Author keyword | 1 | 50% | 1% | 1 |
4 | EA2710 | Address | 1 | 50% | 1% | 1 |
5 | HPRT MUTAGENESIS | Author keyword | 1 | 50% | 1% | 1 |
6 | INTRINSIC RADIATION SENSITIVITY | Author keyword | 1 | 50% | 1% | 1 |
7 | MEK 1 KINASE | Author keyword | 1 | 50% | 1% | 1 |
8 | MURINE HEPATOCARCINOMA | Author keyword | 1 | 50% | 1% | 1 |
9 | NONTRANSFORMED CELLS | Author keyword | 1 | 50% | 1% | 1 |
10 | PROTO ONCOGENE PROTEINS C RAF | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLONOGEN | 1 | 50% | 1% | 1 | Search CLONOGEN | Search CLONOGEN |
2 | COLORADO PARTY | 1 | 50% | 1% | 1 | Search COLORADO+PARTY | Search COLORADO+PARTY |
3 | HPRT MUTAGENESIS | 1 | 50% | 1% | 1 | Search HPRT+MUTAGENESIS | Search HPRT+MUTAGENESIS |
4 | INTRINSIC RADIATION SENSITIVITY | 1 | 50% | 1% | 1 | Search INTRINSIC+RADIATION+SENSITIVITY | Search INTRINSIC+RADIATION+SENSITIVITY |
5 | MEK 1 KINASE | 1 | 50% | 1% | 1 | Search MEK+1+KINASE | Search MEK+1+KINASE |
6 | MURINE HEPATOCARCINOMA | 1 | 50% | 1% | 1 | Search MURINE+HEPATOCARCINOMA | Search MURINE+HEPATOCARCINOMA |
7 | NONTRANSFORMED CELLS | 1 | 50% | 1% | 1 | Search NONTRANSFORMED+CELLS | Search NONTRANSFORMED+CELLS |
8 | PROTO ONCOGENE PROTEINS C RAF | 1 | 50% | 1% | 1 | Search PROTO+ONCOGENE+PROTEINS+C+RAF | Search PROTO+ONCOGENE+PROTEINS+C+RAF |
9 | QUINOXALINE DIOXIDE | 1 | 50% | 1% | 1 | Search QUINOXALINE+DIOXIDE | Search QUINOXALINE+DIOXIDE |
10 | WHOLE BODY IRRADIATION WBI | 1 | 50% | 1% | 1 | Search WHOLE+BODY+IRRADIATION+WBI | Search WHOLE+BODY+IRRADIATION+WBI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RADIORESISTANT | 6 | 47% | 5% | 9 |
2 | ACTIVATED RAS ONCOGENE | 3 | 50% | 2% | 4 |
3 | PLUS V MYC | 3 | 60% | 2% | 3 |
4 | RADIATION RESISTANT CELLS | 2 | 67% | 1% | 2 |
5 | V MYC ONCOGENE | 1 | 38% | 2% | 3 |
6 | ONCOGENES H RAS | 1 | 19% | 4% | 6 |
7 | 4EBP1 | 1 | 50% | 1% | 1 |
8 | CD95 GENE EXPRESSION | 1 | 50% | 1% | 1 |
9 | IRRADIATED ATAXIA TELANGIECTASIA | 1 | 50% | 1% | 1 |
10 | MOLECULAR AGENTS | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The influence of Ras pathway signaling on tumor radiosensitivity | 2004 | 19 | 78 | 37% |
Clinical target promiscuity: lessons from ras molecular trials | 2008 | 6 | 91 | 21% |
Radiation Sensitization by inhibition of activated Ras | 2004 | 18 | 72 | 24% |
Potential molecular targets for manipulating the radiation response | 1997 | 88 | 168 | 9% |
Tumor radiosensitivity and apoptosis | 1999 | 108 | 71 | 8% |
Molecular targets for altering radiosensitivity: Lessons from Ras as a pre-clinical and clinical model | 2005 | 15 | 128 | 17% |
ONCOGENIC BASIS OF RADIATION-RESISTANCE | 1993 | 28 | 133 | 17% |
Radiosensitivity and the cell cycle | 1999 | 21 | 139 | 17% |
Ras regulation of radioresistance in cell culture | 2001 | 8 | 35 | 17% |
Characterization of p21(Ras)-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines | 2004 | 16 | 149 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMARKERS BRANCH | 1 | 50% | 0.6% | 1 |
2 | EA2710 | 1 | 50% | 0.6% | 1 |
3 | UNITE 350 | 1 | 50% | 0.6% | 1 |
4 | NEW ENGLAND MED MED RADIAT ONCOL | 0 | 33% | 0.6% | 1 |
5 | UP EA2710 | 0 | 33% | 0.6% | 1 |
6 | RADIAT ONCOLBRAIN KOREA PROJECT MED SCI 21 | 0 | 25% | 0.6% | 1 |
7 | MEDMALLINCKRODT RADIOL | 0 | 17% | 0.6% | 1 |
8 | RADIAT ONCOL SCI PROGRAM CANC NIH | 0 | 17% | 0.6% | 1 |
9 | RADIOSENSIBIL TUMEURS TISSUS SAINS | 0 | 13% | 0.6% | 1 |
10 | ABRAMSON 916D | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242393 | PREDICTIVE ASSAYS//INDIVIDUAL RADIOSENSITIVITY//NORMAL TISSUE RESPONSE |
2 | 0.0000215277 | NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY |
3 | 0.0000210685 | PEG10//RASPBERRY EXTRACT//NEEM LEAF EXTRACT |
4 | 0.0000196678 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
5 | 0.0000124545 | G2 REPAIR//CHROMATID TYPE ABERRATIONS//G2 M OVERRIDE |
6 | 0.0000123918 | NIMOTUZUMAB//H R3//CETUXIMAB |
7 | 0.0000123788 | RAF//RAF 1//LEO JENKINS CANC |
8 | 0.0000109389 | FARNESYLTRANSFERASE//FARNESYL TRANSFERASE INHIBITOR//FARNESYL TRANSFERASE INHIBITORS |
9 | 0.0000093406 | MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING |
10 | 0.0000091736 | UCN 01//7 HYDROXYSTAUROSPORINE//7 HYDROXYSTAUROSPORINE UCN 01 |